The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2025
Filed:
Mar. 21, 2023
Applicant:
Exact Therapeutics As, Oslo, NO;
Inventors:
Assignee:
Exact Therapeutics AS, Oslo, NO;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 31/454 (2006.01); A61K 31/475 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/52 (2006.01); A61K 31/5377 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01); A61K 41/00 (2020.01); A61K 49/00 (2006.01); A61K 49/22 (2006.01); A61L 24/00 (2006.01); A61P 7/04 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0047 (2013.01); A61K 9/0009 (2013.01); A61K 9/1075 (2013.01); A61K 9/16 (2013.01); A61K 9/19 (2013.01); A61K 31/337 (2013.01); A61K 31/454 (2013.01); A61K 31/475 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/52 (2013.01); A61K 31/5377 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 41/0028 (2013.01); A61K 49/0078 (2013.01); A61K 49/223 (2013.01); A61L 24/001 (2013.01); A61L 24/0015 (2013.01); A61P 7/04 (2018.01); A61L 2300/418 (2013.01); A61L 2300/45 (2013.01); A61L 2300/62 (2013.01); A61L 2430/36 (2013.01);
Abstract
The present disclosure relates to a method of imaging, involving administration of a bi-phasic formulation followed by application of high frequency sound waves to identify a region of interest. Following identification, a phase shift of the bi-phasic formulation may be activated by a second administration of high frequency sound waves such that gaseous components of the bi-phasic formulation are enlarged and localised at the region of interest.